Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tegoprazan–amoxicillin dual therapy vs drug-sensitivity–guided quadruple therapy for Helicobacter pylori rescue treatment
ChiCTR2300077130Phase 4Not yet recruiting
- Sponsor
- Eighth Affiliated Hospital of Sun Yat-sen University
- Start
- Nov 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of tegoprazan in Helicobacter pylori infection (2 arms), sponsored by Eighth Affiliated Hospital of Sun Yat-sen University. Primary endpoint: Helicobacter pylori eradication rate. Planned start Nov 2023; status: not yet recruiting.
02
Drugs
tegoprazan
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on ChiCTR2300077130.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300077130.